» Articles » PMID: 27078083

Vascular Endothelial Growth Factor-A Gene Electrotransfer Promotes Angiogenesis in a Porcine Model of Cardiac Ischemia

Overview
Journal Gene Ther
Date 2016 Apr 15
PMID 27078083
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to assess safety and therapeutic potential of gene electrotransfer (GET) as a method for delivery of plasmid encoding vascular endothelial growth factor A (VEGF-A) to ischemic myocardium in a porcine model. Myocardial ischemia was induced by surgically occluding the left anterior descending coronary artery in swine. GET following plasmid encoding VEGF-A injection was performed at four sites in the ischemic region. Control groups either received injections of the plasmid without electrotransfer or injections of the saline vehicle. Animals were monitored for 7 weeks and the hearts were evaluated for angiogenesis, myocardial infarct size and left ventricular contractility. Arteriograms suggest growth of new arteries as early as 2 weeks after treatment in electrotransfer animals. There is a significant reduction of infarct area and left ventricular contractility is improved in GET-treated group compared with controls. There was no significant difference in mortality of animals treated with GET of plasmid encoding VEGF-A from the control groups. Gene delivery of plasmid encoding VEGF-A to ischemic myocardium in a porcine model can be accomplished safely with potential for myocardial repair and regeneration.

Citing Articles

Two promising approaches in the treatment of myocardial infarction: stem cells and gene therapy.

Gao S, Li D, Wang B, Zhang H, Chen L Front Cardiovasc Med. 2025; 12:1540066.

PMID: 40046966 PMC: 11880279. DOI: 10.3389/fcvm.2025.1540066.


Genetically engineered HEK cells as a valuable tool for studying electroporation in excitable cells.

Batista Napotnik T, Kos B, Jarm T, Miklavcic D, OConnor R, Rems L Sci Rep. 2024; 14(1):720.

PMID: 38184741 PMC: 10771480. DOI: 10.1038/s41598-023-51073-5.


Characterization of Experimentally Observed Complex Interplay between Pulse Duration, Electrical Field Strength, and Cell Orientation on Electroporation Outcome Using a Time-Dependent Nonlinear Numerical Model.

Scuderi M, Dermol-Cerne J, Batista Napotnik T, Chaigne S, Bernus O, Benoist D Biomolecules. 2023; 13(5).

PMID: 37238597 PMC: 10216437. DOI: 10.3390/biom13050727.


Gene Therapy of Chronic Limb-Threatening Ischemia: Vascular Medical Perspectives.

Simon F, Duran M, Garabet W, Schelzig H, Jacobs M, Gombert A J Clin Med. 2022; 11(5).

PMID: 35268373 PMC: 8910863. DOI: 10.3390/jcm11051282.


Vascular Endothelial Growth Factor as a Putative Biomarker of Depression in Asthmatics with Reversible Airway Narrowing.

Gomulka K, Liebhart J, Medrala W J Clin Med. 2021; 10(22).

PMID: 34830591 PMC: 8622768. DOI: 10.3390/jcm10225301.


References
1.
Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann W, Zeiher A . Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol. 2005; 39(5):733-42. DOI: 10.1016/j.yjmcc.2005.07.003. View

2.
Ayuni E, Gazdhar A, Giraud M, Kadner A, Gugger M, Cecchini M . In vivo electroporation mediated gene delivery to the beating heart. PLoS One. 2011; 5(12):e14467. PMC: 3012686. DOI: 10.1371/journal.pone.0014467. View

3.
. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985; 312(14):932-6. DOI: 10.1056/NEJM198504043121437. View

4.
Wolfram J, Donahue J . Gene therapy to treat cardiovascular disease. J Am Heart Assoc. 2013; 2(4):e000119. PMC: 3828796. DOI: 10.1161/JAHA.113.000119. View

5.
Tao Z, Chen B, Tan X, Zhao Y, Wang L, Zhu T . Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci U S A. 2011; 108(5):2064-9. PMC: 3033313. DOI: 10.1073/pnas.1018925108. View